Glioma cells release neurotoxic glutamate, partly via cystine/glutamate exchangers, to stimulate proliferation; reduced EAAT1/2 (especially EAAT2) in glioblastoma (GBM) impairs glutamate clearance, enhancing accumulation [457, 459, 460]. Here, SLC1A2 is linked to glioblastoma.